Calcium Chloride 10% In Plastic Container

(Calcium chloride)

Phase 3Small molecule

Calcium Chloride 10% In Plastic Container is one of 133 small molecule programs targeting Cardiac Arrest. It is currently in Phase 3.

Indications

Total Trials

Active Trials

132

Competitors

FDA Application

NDA/BLA/ANDA regulatory filings

Pipeline

Status by Indication[3][1]

Indication

Cardiac ArrestActive, not recruiting

Basal Cell CarcinomaActive, not recruiting

KeloidActive, not recruiting

Atrial FibrillationActive, not recruiting

Cardiac ArrestPhase 2

Active, not recruiting

Basal Cell CarcinomaPhase 3

Active, not recruiting

KeloidPhase 1

Active, not recruiting

Atrial FibrillationPhase 3

Active, not recruiting

Competition

Competitive Landscape

376 competitors in Atrial Fibrillation

#DrugCompanyPhaseTrials

Calcium Chloride 10% In Plastic Container

Pfizer

Phase 3

1 2

Calquence

AstraZeneca

Preclinical

1 3

Calan

VVal Adams

Preclinical

4 4

Rituxan

Roche

Preclinical

—5

Versed

CConrado Roberto Hoffmann Filho

Preclinical

1 6

Ondexxya

UUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

Preclinical

1 7

Imbruvica

PPharmacyclics LLC.

Preclinical

1 8

Romazicon

CConrado Roberto Hoffmann Filho

Preclinical

1 9

Xylocaine

MMEDRx USA, Inc.

Preclinical

1 10

Brukinsa

BBeOne Medicines

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

N/ARecruiting

Cesarean Delivery

NCT07187544

Clinical

Trials by Indication[1]

Cesarean Delivery2 trials

Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery

Recruiting·SSamuel Lunenfeld Research Institute, Mount Sinai Hospital·N/A·NCT07187544·120 enrolled

Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery

Completed·SStanford University·Phase 3·NCT05027048·120 enrolled

Keloid1 trial

Calcium Electroporation for the Treatment of Keloids

Completed·HHerlev Hospital·Phase 1·NCT01941914·7 enrolled

Cardiopulmonary Bypass1 trial

A Trial of Intravenous Calcium and Myocardial Diastolic Dysfunction During Separation From Cardiopulmonary Bypass

Terminated·—·Phase 4·NCT00955266·8 enrolled

Atrial Fibrillation1 trial

Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG

Recruiting·HHelwan University·Phase 3·NCT06378021·100 enrolled

Basal Cell Carcinoma1 trial

Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Unknown status·—·Phase 3·NCT05046262·25 enrolled

7 more indications

Head and Neck Cancer1 trial

Calcium Electroporation for Head and Neck Cancer

Unknown status·RRigshospitalet, Denmark·Phase 1·NCT03051269·6 enrolled

Cardiac Surgery1 trial

Calcium Administration in Cardiac Surgery

Completed·MMeshalkin Research Institute of Pathology of Circulation·Phase 4·NCT03772990·818 enrolled

Metastases1 trial

Calcium Electroporation for Treatment of Cutaneous Metastases

Completed·HHerlev Hospital·Phase 2·NCT01941901·7 enrolled

ART1 trial

Pharmacokinetic Equivalence of Calcium Gluconate and Calcium Chloride in Parturients

Completed·SStanford University·Phase 1·NCT05973747·34 enrolled

Cardiac Arrest1 trial

Calcium for Out-of-Hospital Cardiac Arrest

Completed·LLars Wiuff Andersen·Phase 2·NCT04153435·397 enrolled

Pilot Study1 trial

Effect of Changing Physiological Conditions on Myogenic Oscillations: Pilot Study

Completed·UUniversity of California, San Francisco·Phase 1·NCT03719001·40 enrolled

Uterine Atony1 trial

Calcium Chloride for Prevention of Uterine Atony During Cesarean

Completed·SStanford University·Phase 1/2·NCT03867383·40 enrolled

Regulatory

FDA Approval Timeline[4]

Jan 28, 2000

CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER

NDA NDA021117

Sources

References

[1]
ClinicalTrials.gov — 13 trial records for Calcium chloride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Calcium chloride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Calcium chloride. EMBL-EBI & Wellcome Sanger Institute.
[4]
OpenFDA — FDA approval records (NDA NDA021117). U.S. Food & Drug Administration.
[5]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Pfizer

Calcium Chloride 10% In Plastic Container

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2026

Trials by Indication[1]

Cesarean Delivery2 trials

Keloid1 trial

Cardiopulmonary Bypass1 trial

Atrial Fibrillation1 trial

Basal Cell Carcinoma1 trial

Head and Neck Cancer1 trial

Cardiac Surgery1 trial

Metastases1 trial

ART1 trial

Cardiac Arrest1 trial

Pilot Study1 trial

Uterine Atony1 trial

FDA Approval Timeline[4]

References

Drug Info

Quick Facts

Related News